About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Efpeglenatide

Company: Sanofi
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Trial details

Completed NCT NCT03353350

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise

Not yet reported Hanmi Pharmaceutical Company Limited 406 participants Est. completion 2020-09-07 54 sites Stand-alone

Type 2 diabetes
View official trial listing →
Terminated NCT NCT03496298

Effect of Efpeglenatide on Cardiovascular Outcomes

Not yet reported Sanofi 4076 participants Est. completion 2020-12-10 353 sites Stand-alone

Type 2 diabetes
View official trial listing →
Terminated NCT NCT03684642

Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

Not yet reported Sanofi 908 participants Est. completion 2020-11-17 45 sites Stand-alone

Type 2 diabetes
View official trial listing →
Terminated NCT NCT03713684

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)

Not yet reported Sanofi 370 participants Est. completion 2021-01-04 47 sites Stand-alone

Type 2 diabetes
View official trial listing →
Terminated NCT NCT03770728

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea

Not yet reported Sanofi 312 participants Est. completion 2020-12-27 48 sites Stand-alone

Type 2 diabetes
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT03496298

Also known as: Efpeglenatide, Efpeglenatide (SAR439977)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.